← All trials
NCT04716712
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 4, 2021
- Primary completion
- Jan 30, 2025
- Completion date
- Jan 30, 2025
- First posted
- Jan 20, 2021
- Last posted
- Sep 13, 2021
- Enrollment
- 694400
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, San FranciscoLead sponsor
- University of California, San FranciscoOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- Centre de Recherche en Sante de Nouna, Burkina FasoCollaborator
- Helen Keller InternationalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.